We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Asia-Pacific Compression Therapy Market Outlook to 2020

Asia-Pacific Compression Therapy Market Outlook to 2020

  • $ 3 000
  • Industry report
  • by Global Data
  • October 2014
  • 268 pages

Asia-Pacific Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Compression Therapy Market Outlook to 2020", provides key market data on the Asia-Pacific Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average ...

Industries: Therapy | Countries: South Korea, Australia, China, India, Japan, Asia, World, Oceania

Asia Pacific NIPT Market Outlook 2018

Asia Pacific NIPT Market Outlook 2018

  • $ 1 400
  • Industry report
  • by RNCOS
  • September 2014
  • 55 pages

Non-Invasive Prenatal Testing (NIPT) has catapulted growth in the molecular diagnostics market. In the US, where the test was initially launched, the market is expected to grow at a CAGR of 49% during 2013-2018. However, owing to a restrictive potential population base in USA, which is estimated at around ...

Industries: Drug Discovery and Development | Countries: Australia, India, Japan, China, Asia, World, Oceania

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

  • $ 4 995
  • Industry report
  • by GBI Research
  • August 2014
  • 105 pages

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM Summary GBI Research, the leading business intelligence provider, has released its latest research, "Glioblastoma Multiforme Therapeutics in ...

Industries: Therapy | Countries: Australia, India, Japan, China, World, United States, Asia, Oceania

Asia-Pacific Hernia Repair Procedures Outlook to 2020

Asia-Pacific Hernia Repair Procedures Outlook to 2020

  • $ 450
  • Industry report
  • by Global Data
  • July 2014
  • 341 pages

Asia-Pacific Hernia Repair Procedures Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Hernia Repair Procedures Outlook to 2020", provides key market data on the Asia-Pacific Hernia Repair Procedures. The report provides procedure volumes within market segments - Inguinal Hernia Repai ...

Industries: Pathology | Countries: South Korea, Australia, China, India, Japan, Asia, World, Oceania

Asia-Pacific Hernia Repair Market Outlook to 2020

Asia-Pacific Hernia Repair Market Outlook to 2020

  • $ 3 000
  • Industry report
  • by Global Data
  • July 2014
  • 126 pages

Asia-Pacific Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Hernia Repair Market Outlook to 2020", provides key market data on the Asia-Pacific Hernia Repair market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US ...

Industries: Pathology | Countries: South Korea, Australia, Japan, India, China, Asia, World, Oceania

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 45 pages

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 45 pages

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, World, United States, Spain, Italy, France, Germany, United Kingdom, Europe, Oceania

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 45 pages

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Oceania

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 47 pages

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, Oceania

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 45 pages

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Oceania

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.